Empowered Patient Podcast

Paul Romness , CEO, President, and Chair of OS Therapies, which is developing an immunotherapy to treat osteosarcoma, a rare bone cancer that stimulates the immune system to identify and eliminate cancer cells. The approach upregulates positive immune factors amd downregulates negative factors resulting in a dual biomarker response and better management of side effects. OS Therapies plans to expan...

Paul Romness , CEO, President, and Chair of OS Therapies, which is developing an immunotherapy to treat osteosarcoma, a rare bone cancer that stimulates the immune system to identify and eliminate cancer cells. The approach upregulates positive immune factors amd downregulates negative factors resulting in a dual biomarker response and better management of side effects. OS Therapies plans to expan...

Dejan Nenov  is the Founder of Luventix, an AI-powered diagnostic platform that uses machine learning to analyze metabolic data from urine samples to detect multiple diseases and health conditions.  This approach, inspired by the ability of dogs to detect cancer through smell, enables a single non-invasive test to screen for conditions across oncology, neurology, immunology, and other areas at a f...

Dejan Nenov  is the Founder of Luventix, an AI-powered diagnostic platform that uses machine learning to analyze metabolic data from urine samples to detect multiple diseases and health conditions.  This approach, inspired by the ability of dogs to detect cancer through smell, enables a single non-invasive test to screen for conditions across oncology, neurology, immunology, and other areas at a f...

Dr. Hansa Bhargava , Chief Clinical Strategy and Innovation Officer at Healio,  discusses the Healio survey of healthcare professionals to understand evolving attitudes toward AI in clinical practice.  While a significant number of clinicians are leaning into AI adoption, significant trust gaps persist regarding accuracy, data privacy and liability concerns. As AI capabilities advance rapidly, hea...

Dr. Hansa Bhargava , Chief Clinical Strategy and Innovation Officer at Healio,  discusses the Healio survey of healthcare professionals to understand evolving attitudes toward AI in clinical practice.  While a significant number of clinicians are leaning into AI adoption, significant trust gaps persist regarding accuracy, data privacy and liability concerns. As AI capabilities advance rapidly, hea...

Dr. Carl Rothschild , CEO and Founder, and  Eddie Brown , COO of Trifecta Light Technologies, discuss the therapeutic applications of red light and near-infrared therapy by bathing the entire body with these specific light wavelengths. The technology has FDA clearance for fat reduction and healing and clinical research indicates efficacy in neurological disorders and musculoskeletal conditions. Th...

Dr. Carl Rothschild , CEO and Founder, and  Eddie Brown , COO of Trifecta Light Technologies, discuss the therapeutic applications of red light and near-infrared therapy by bathing the entire body with these specific light wavelengths. The technology has FDA clearance for fat reduction and healing and clinical research indicates efficacy in neurological disorders and musculoskeletal conditions. Th...

James Sapirstein , CEO of CoCrystal Pharma, is developing a platform of antiviral therapies to treat norovirus, influenza and other viruses.  Norovirus, commonly transmitted on cruise ships and in dormitories, currently lacks effective vaccines or treatments. CoCrystal's oral small-molecule approach aims to treat active infections by reducing viral shedding duration and provide prophylactic preven...

James Sapirstein , CEO of CoCrystal Pharma, is developing a platform of antiviral therapies to treat norovirus, influenza and other viruses.  Norovirus, commonly transmitted on cruise ships and in dormitories, currently lacks effective vaccines or treatments. CoCrystal's oral small-molecule approach aims to treat active infections by reducing viral shedding duration and provide prophylactic preven...

Dr. Claire Smith, a regional medical officer at SCP Health and a practicing hospitalist in Missouri, highlights how virtual hospitalists are transforming healthcare by providing 24/7 physician collaboration to support onsite teams, particularly in rural hospitals and during patient surges. Implementing telehospitalists can play a critical role in reducing clinician burnout, improving access to phy...

Dr. Claire Smith, a regional medical officer at SCP Health and a practicing hospitalist in Missouri, highlights how virtual hospitalists are transforming healthcare by providing 24/7 physician collaboration to support onsite teams, particularly in rural hospitals and during patient surges. Implementing telehospitalists can play a critical role in reducing clinician burnout, improving access to phy...

Dr. Mark George is the principal psychiatric investigator of Abbott's TRANSCEND study and also a professor of psychiatry at MUSC Health Institute of Psychiatry.  The TRANSCEND study represents a paradigm shift in depression treatment by investigating deep brain stimulation as a potential solution for treatment-resistant depression. This research involves surgically implanting a device that deliver...

Dr. Mark George is the principal psychiatric investigator of Abbott's TRANSCEND study and also a professor of psychiatry at MUSC Health Institute of Psychiatry.  The TRANSCEND study represents a paradigm shift in depression treatment by investigating deep brain stimulation as a potential solution for treatment-resistant depression. This research involves surgically implanting a device that deliver...

Dr. Manish Arora , CEO at LinusBio, has developed an innovative approach to precision medicine through the Traced test, which measures exposure to trace elements and environmental toxins using hair biomarkers. The technology analyzes a small hair sample and can measure chemicals that enter the bloodstream and deposit in the hair as it grows.  This exposome-based test identifies exposure patterns t...

Dr. Manish Arora , CEO at LinusBio, has developed an innovative approach to precision medicine through the Traced test, which measures exposure to trace elements and environmental toxins using hair biomarkers. The technology analyzes a small hair sample and can measure chemicals that enter the bloodstream and deposit in the hair as it grows.  This exposome-based test identifies exposure patterns t...

Xiaoxi Wei , CEO and Co-Founder of X-Therma, is revolutionizing organ transplantation by extending the preservation time of donor organs through advanced biopreservation technology. This approach addresses the gap in organ transplantation that exists because of limitations of cold storage, which constrains the hours of viability of an organ and results in over 50% of donated organs going unused. ...

Xiaoxi Wei , CEO and Co-Founder of X-Therma, is revolutionizing organ transplantation by extending the preservation time of donor organs through advanced biopreservation technology. This approach addresses the gap in organ transplantation that exists because of limitations of cold storage, which constrains the hours of viability of an organ and results in over 50% of donated organs going unused. ...

Dr. Rachel Artsma , lead audiologist at hear.com offers comprehensive hearing care services and she emphasizes how dramatically hearing aids have evolved from earlier generations. Bluetooth connectivity, rechargeable batteries, and real-time environmental adjustments are now being driven by smart chips in the devices, which also allow direct streaming of phone calls, music, and driving directions....

Dr. Rachel Artsma , lead audiologist at hear.com offers comprehensive hearing care services and she emphasizes how dramatically hearing aids have evolved from earlier generations. Bluetooth connectivity, rechargeable batteries, and real-time environmental adjustments are now being driven by smart chips in the devices, which also allow direct streaming of phone calls, music, and driving directions....

Amy Gordon Franzen , CEO of Rune Labs, developed StrivePD, a patient-facing app that supports those with Parkinson's disease by passively tracking their movements and collecting longitudinal data on tremor, gait, and activity patterns. The technology addresses a critical gap in neurodegenerative disease management by providing continuous, objective data that enables patients and clinicians to make...

Amy Gordon Franzen , CEO of Rune Labs, developed StrivePD, a patient-facing app that supports those with Parkinson's disease by passively tracking their movements and collecting longitudinal data on tremor, gait, and activity patterns. The technology addresses a critical gap in neurodegenerative disease management by providing continuous, objective data that enables patients and clinicians to make...

Dr. Sid Kerkar , CEO and Founder of AllerGene AI Therapeutics, is developing in vivo gene therapy for severe food allergies, where symptoms are currently treated rather than root causes. AllerGene AI is targeting mast cells, which are immune cells responsible for triggering allergic reactions, and their approach represents a significant opportunity to prevent these reactions. Unlike traditional ce...

Dr. Sid Kerkar , CEO and Founder of AllerGene AI Therapeutics, is developing in vivo gene therapy for severe food allergies, where symptoms are currently treated rather than root causes. AllerGene AI is targeting mast cells, which are immune cells responsible for triggering allergic reactions, and their approach represents a significant opportunity to prevent these reactions. Unlike traditional ce...

Dr. David Feldman is the Chief Medical Officer at Dimer Health, a virtual care medical practice designed to improve patient outcomes during the critical 1-3 days following hospital discharge, outpatient surgery, or emergency room visits.  The company addresses the gap in post-acute care between hospital care and primary care follow-up by proactive monitoring, medication management, and pain contro...